0430 : Predictors of long-term clinical outcomes in acute coronary syndrome treated with everolimus-eluting stent

Background Everolimus-eluting stent (EES) improves long-term prognosis in patients with acute coronary syndrome (ACS) and is currently recommended over bare metal stent (BMS) in this population. Nevertheless, predictors of long-term outcomes in ACS patients treated with EES have not been evaluated in routine practice. Methods We retrospectively included patients treated with EES for ACS between June 2012 and December 2013 in our institution. Baseline clinical, biological and procedural characteristics were collected and all patients completed at least one-year follow-up. The primary endpoint was defined as the composite of target-vessel revascularization (TVR), target-vessel myocardial infarction (MI), or cardiac death at one year. Results of 447 patients included, 67 patients (15.1%) reached the primary endpoint at one year. In a multivariate analysis using Cox regression model, cardiogenic shock (HR 6.74; 95% CI [5-18.6]; p Conclusion in ACS patients treated with EES, cardiogenic shock and baseline anemia were the most robust predictors of long-term adverse clinical outcomes. The author hereby declares no conflict of interest